Michael Glodé
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Pancreatic and Hepatic Oncology Research 1
- Chemokine receptors and signaling 1
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Vic Raso (1 shared paper)Glenn Steele (1 shared paper)William D. Ensminger (1 shared paper)Steven E. Come (1 shared paper)David C. Levin (1 shared paper)Emil Frei (1 shared paper)A. Rosowsky (1 shared paper)Thomas W. Flaig (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)The Prostate (1 paper)Clinical Cancer Research (1 paper)Journal of Immunotherapy (1 paper)Oncology Reports (1 paper)
- Partner nations
- United StatesNepalIndia
In The Last Decade
Michael Glodé
11 papers receiving 880 citations
Michael Glodé's Hit Papers
Peers
Comparison fields: 5 of 83
- Hepatology 233
- Oncology 307
- Pulmonary and Respiratory Medicine 253
- Cancer Research 77
- Biotechnology 41
Countries citing papers authored by Michael Glodé
This map shows the geographic impact of Michael Glodé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Glodé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Glodé more than expected).
Fields of papers citing papers by Michael Glodé
This network shows the impact of papers produced by Michael Glodé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Glodé. The network helps show where Michael Glodé may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Glodé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Hit paper breakdown → | 1978 | 414 |
| 2 | 2010 | 152 | |
| 3 | 2011 | 116 | |
| 4 | Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma. | 2000 | 107 |
| 5 | 2008 | 48 | |
| 6 | 2002 | 39 | |
| 7 | 2006 | 17 | |
| 8 | 2007 | 12 | |
| 9 | 2010 | 10 | |
| 10 | Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation. | 1984 | 5 |
| 11 | Endotoxin unresponsiveness in C3H/HEJ mice | 1975 | 1 |
| 12 | 2004 | 1 | |
| 13 | 2019 | 0 |
About Michael Glodé
Michael Glodé is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Molecular Biology, having authored 13 papers that have together received 922 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Advanced Radiotherapy Techniques (1 paper), Ubiquitin and proteasome pathways (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Hepatology (233 citations), Oncology (307 citations), Pulmonary and Respiratory Medicine (253 citations), Cancer Research (77 citations) and Biotechnology (41 citations). Michael Glodé has collaborated with scholars based in United States, Nepal and India. Frequent co-authors include Vic Raso, Glenn Steele, William D. Ensminger, Steven E. Come, David C. Levin, Emil Frei, A. Rosowsky, Thomas W. Flaig, Mohammad Asif Hussain and Wei Du. Their work appears in journals such as Journal of Clinical Oncology, The Prostate, Clinical Cancer Research, Journal of Immunotherapy and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.